+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hantavirus-specific IgG, IgM, and IgA in acute and chronic renal disease versus congenital renal disease in the United States



Hantavirus-specific IgG, IgM, and IgA in acute and chronic renal disease versus congenital renal disease in the United States



American Journal of Kidney Diseases 33(4): 734-737



In a blinded fashion, 165 serum samples from patients with biopsy-characterized acute and chronic renal diseases (ACRDs), 34 serum samples from patients with congenital renal diseases (CRDs), and 100 serum samples from healthy adults were assayed for immunoglobulin G (IgG), IgM, and IgA antibodies to Hantaan and Puumala viruses by enzyme immunoassay (EIA). Twenty-six percent (44 of 165) of ACRDs, 3% (1 of 34) of CRDs, and none (0 of 100) of the healthy serum samples were positive for hantavirus-specific antibodies (P < 0.001, Fisher's exact test). Thirty of 44 positive serum samples (68%) were from three groups: ie, acute tubulointerstitial nephritis (AIN), 20% (9 of 44); necrotizing glomerulonephritis (NG), 27% (12 of 44); and IgA nephropathy, 20% (9 of 44). The remaining 14 positive samples were from patients with a varied group of renal conditions. IgA antibody levels alone were elevated in 37%, IgG alone in 33%, IgM alone in 17%, and all three isotypes in 13% of the AIN-, NG-, and IgA-positive samples. These data indicate that three renal diseases account for approximately 68% of the hantavirus-positive sera tested and that serological evaluations should include all three isotypes of antibodies.

(PDF emailed within 0-6 h: $19.90)

Accession: 046211925

Download citation: RISBibTeXText

PMID: 10196017

DOI: 10.1016/s0272-6386(99)70227-1


Related references

Hantavirus specific IgG, IgM, and IgA antibodies in acute and chronic renal disease in the United States. Journal of the American Society of Nephrology 7(9): 1396, 1996

'United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. American Journal of Kidney Diseases 59(1 Suppl 1): A7, E1-A7,420, 2012

Renal failure and acute myocardial infarction: clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction. American Heart Journal 163(3): 399-406, 2012

Discrepancy in the epidemiology of nondiabetic chronic renal insufficiency and end-stage renal disease in black and white Americans: the third National Health and Nutrition Examination Survey and United States Renal Data System. American Journal of Nephrology 23(6): 448-457, 2003

Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. Journal of the American Society of Nephrology 14(11): 2902-2907, 2003

Temporal trends in the incidence end-stage renal disease relative to the prevalence of chronic renal insufficiency in the United States. Journal of the American Society of Nephrology 14(Abstracts Issue): 194A, November, 2003

The Hantaviruses, etiologic agents of hemorrhagic fever with renal syndrome: a possible cause of hypertension and chronic renal disease in the United States. Annual Review of Public Health 13: 79-98, 1992

Excerpts from the United States Renal Data Systems 2002 annual report: Atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases 41(4 Suppl 2): V-Ix, S7-254, 2003

Disease-specific growth charts for prepubertal children with chronic renal failure due to congenital renal disorders. Pediatric Nephrology 8(5): C39, 1994

The John F. Maher Award Recipient Lecture 2006. The continuum of chronic kidney disease and end-stage renal disease: challenges and opportunities for chronic peritoneal dialysis in the United States. Peritoneal Dialysis International 27(2): 125-130, 2007

Racial differences in chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States: a social and economic dilemma. Clinical Nephrology 74 Suppl 1: S72-S77, 2011

End-stage renal disease in the United States: an update from the United States Renal Data System. Journal of the American Society of Nephrology 18(10): 2644-2648, 2007

Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. Journal of the American Society of Nephrology 16(2): 489-495, 2004

Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases 42(6 Suppl 5): A5-7, S1-230, 2003

Excerpts from the United States Renal Data System 2004 annual data report: atlas of end-stage renal disease in the United States. American Journal of Kidney Diseases 45(1 Suppl 1): A5-7, S1-280, 2005